We also detected four novel T2D-associated genes using our gene-based test of population heterogeneity: CA6, CCT3, KRT8, and ASIC2. Previous studies indicate that CA6 protein abundance in plasma differs between T2D patients with and without β-cell dysfunction (Belongie et al., 2017). This evidence concerns the gene CA6 and type 2 diabetes mellitus.